Posted by Michael Wonder on 21 Jul 2020
Harnessing real world data for regulatory use and applying innovative applications
22 July 2020 - A vast quantity of real world data are available to health care researchers.
Such data come from diverse sources such as electronic health records, insurance claims and billing activity, product and disease registries, medical devices used in the home, and applications on mobile devices. The analysis of real world data produces real world evidence, which is clinical evidence that provides information about usage and potential benefits or risks of a drug.
This review from researchers at Pfizer defines and explains real world data, and it also details how regulatory authorities are using real world data and real world evidence.
